36 Years of Experience
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Parsonnet, Infectious Disease Specialist in Stanford, CA?
Dr. Julie Parsonnet, MD is an Infectious Disease Specialist, who primarily practices in Stanford, CA with 1 additional practice location. She has been practicing for over 36 years and is board certified. Dr. Parsonnet graduated from Jawaharlal Institute of Post Graduate Medicine Research, Pondicherry University and completed her residency at Mass Gen Hosp, Internal Medicine. Dr. Parsonnet is fluent in English, French, and Spanish, and is currently seeing new patients. Dr. Parsonnet’s practice accepts Medicaid, Medicare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Parsonnet’s office at (650) 723-4000.
Where did Dr. Parsonnet go to medical school and complete their residency?
Fellowship: Massachusetts General Hospital MA | Massachusetts General Hospital
Residency: Mass Gen Hosp, Internal Medicine | Massachusetts General Hospital
Medical School: Jawaharlal Institute of Post Graduate Medicine Research, Pondicherry University
Is Dr. Parsonnet board certified as an Infectious Disease Specialist?
Yes, Dr. Julie Parsonnet, MD is board certified by the American Board of Internal Medicine since 1986, American Board of Internal Medicine since 1988
What languages does Dr. Parsonnet speak?
Dr. Parsonnet and their clinical team can communicate with patients in the following languages:
English
French
Spanish
What conditions does an Infectious Disease Specialist like Dr. Parsonnet typically treat?
As an Infectious Disease Specialist, Dr. Parsonnet diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Parsonnet. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Latent Tuberculosis
- Lung Tuberculosis
- Tuberculosis
- Inactive TB
- Latent TB Infection
- Hidden TB
- Pulmonary Tuberculosis
- TB of the Lungs
- Consumption
ICD-10 Codes:
- Z227: Latent tuberculosis
- A150: Tuberculosis of lung
Also known as:
- Urinary Tract Infection
- UTI
- Bladder infection
- Kidney infection
- Urine infection
ICD-10 Codes:
- N390: Urinary tract infection, site not specified
Also known as:
- Valley Fever Meningitis
- Widespread Valley Fever
- Meningitis
- Valley Fever
- Fungal meningitis (Valley Fever)
- Coccidioidal meningitis
- Brain infection from Valley Fever
- Systemic coccidioidomycosis
- Valley Fever spread throughout body
- Severe desert rheumatism
ICD-10 Codes:
- B384: Coccidioidomycosis meningitis
- B387: Disseminated coccidioidomycosis
Also known as:
- Abnormal Tuberculosis Blood Test Result
- Positive TB Blood Test
- Interferon Gamma Release Assay Reaction
- IGRA Positive
ICD-10 Codes:
- R7612: Nonspecific reaction to cell mediated immunity measurement of gamma interferon antigen response without active tuberculosis
Also known as:
- Blood Infection
- Sepsis
- Bacteremia
- Bacteria in blood
- Bloodstream infection
ICD-10 Codes:
- R7881: Bacteremia
What procedures does an Infectious Disease Specialist like Dr. Parsonnet typically perform?
As an Infectious Disease Specialist, procedures performed by Dr. Julie Parsonnet may include:
- Epidemiology Consultation
- Epidemiology Follow Up
- HIV / AIDS Consultation
- HIV / AIDS Follow Up
- Human Papillomavirus (HPV) Vaccine
- Infection Follow Up
- Lumbar Puncture
- Pertussis Vaccine
Please contact Dr. Parsonnet's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Parsonnet accept my insurance?
Dr. Parsonnet accepts most major insurance plans. Important: Please call our office at (650) 723-4000 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Parsonnet accept in Stanford, CA?
Dr. Parsonnet in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
All Other Third Party
Blue Shield of California
Centene Corporation
Cigna Group
CVS Health (formerly Aetna)
Medicaid
Medicare
Santa Cruz County
State of California
UnitedHealth Group
View All Insurances
Where is Dr. Parsonnet's office located?
Recognitions
Awards
George DeForest Barnett Professorship, Stanford
Stanford University
Henry J. Kaiser Family Foundation Award for Excellence in Preclinical
Stanford University
Henry J. Kaiser Award for Innovation in Medical Education
Member, American Society for Clinical Investigation
Best Doctors (.)
Publications
Cultivation and Serological Characterization of a Human Theiler's
, 2010
Infection with Helicobacter pylori Is Associated with Protection against Tuberculosis
, 2010
Cost-Effectiveness of a Potential Prophylactic Helicobacter pylori Vaccine in the United States
, 2009
Identification of cardioviruses related to Theiler's murine encephalomyelitis virus
, 2008
Gastroenteritis and transmission of Helicobacter pylori infection in households
, 2006
Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma
, 2005
Fecal and oral shedding of Helicobacter pylori from healthy infected adults
, 1999
HELICOBACTER-PYLORI INFECTION AND GASTRIC LYMPHOMA
, 1994
HELICOBACTER-PYLORI INFECTION AND THE RISK OF GASTRIC-CARCINOMA
, 1991
The immune response to tuberculosis infection in the setting of Helicobacter pylori
, 2013
Decreasing Intestil Parasites in Recent Northern California Refugees
, 2013
Local epidemic history as a predictor of tuberculosis incidence
, 2011
The impact of mucosal infections on acquisition and progression of tuberculosis
, 2011
Clinical Application
, 2011
Effect of Helicobacter pylori Infection on Symptoms of G
, 2011
Role of Bacteria in Oncogenesis
, 2010
Immediate Incubation Reduces Indetermite Results for QuantiFERON-TB Gold In-Tube Assay
, 2010
Encouraging Scholarship
, 2010
Engaging Students in Dedicated Research and Scholarship During Medical School
, 2010
Required vs. Elective Research and In-Depth Scholarship Programs in the Medical Student Curriculum
, 2010
Helicobacter pylori and gastric adenocarcinoma
, 2009
The complete genome of klassevirus - a novel picorvirus in pediatric stool
, 2009
Helicobacter species in cancers of the gallbladder and extrahepatic biliary tract
, 2009
Estimating disease prevalence using census data
, 2008
Helicobacter pylori infection and development of pancreatic cancer
, 2008
Reproducibility of QuantiFERON-TB gold in-tube assay
, 2008
Cerebral myiasis associated with angiosarcoma of the scalp: case report.
, 2007
Serum ghrelin levels and risk of subsequent adenocarcinoma of the esophagus
, 2007
Helicobacter pylori infection and gender: A meta-alysis of population-based prevalence surveys
, 2006
Acquisition of Helicobacter pylori infection in rhesus macaques is most consistent with oral
, 2006
Concordance of Helicobacter pylori infection among children in extended-family homes
, 2006
Investigation of mediastinitis due to coagulase-negative staphylococci after cardiothoracic surgery
, 2006
Associations of serologic markers of infection and inflammation with vascular disease events
, 2006
Changes of gene expression in gastric preneoplasia following Helicobacter pylori eradication
, 2006
Validation of the blood quininium resin test for assessing gastric hypochlorhydria
, 2006
Clinician-discoverers - Marshall, Warren, and H-Pylori
, 2005
Commentary: H. pylori infection in early life and the problem of imperfect tests
, 2005
Cell proliferation and inflammation on biopsy samples with multifocal atrophic g
, 2005
QuantiFERON (R)-TB predicts tuberculin skin test boosting in US foreign-born
, 2005
Helicobacter pylori infection in different generations of Hispanics in the San Francisco Bay Area
, 2005
Risk of intestil helminth and protozoan infection in a refugee population
, 2005
Use of insecticide-treated nets (ITNs) following a malaria education intervention in Piron, Mali
, 2005
Household transmission of gastroenteritis
, 2005
Significance of transiently positive enzyme
, 2005
Helicobacter pylori and risk of gastroenteritis
, 2004
Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons
, 2004
Bacterial infection and MALT lymphoma
, 2004
Helicobacter pylori infection and gastric cancer - For want of more outcomes
, 2004
Helicobacter pylori eradication and gastric preneoplastic conditions: A randomized, double-blind
, 2004
tural acquisition of Helicobacter pylori infection in newborn rhesus Macaques
, 2003
What is the Helicobacter pylori global reinfection rate?
, 2003
C-reactive protein, Helicobacter pylori
, 2003
Variability in antibiotic prescribing patterns
, 2003
Helicobacter pylori in cathartic stools of subjects with
, 2003
No association between Helicobacter pylori
, 2003
Diagnostic yield of gastric biopsy specimens when screening for preneoplastic lesions
, 2003
Growth slowing after acute Helicobacter pylori infection is age-dependent
, 2002
Eradication rate of Helicobacter pylori in a Mexican population at high risk for gastric cancer
, 2002
[High frequency of precancerous lesions of gastric cancer associated with Helicobacter pylori
, 2002
Helicobacter pylori: Consensus and controversy
, 2002
A modification of the quininium resin test for assessing gastric acidity
, 2002
CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma
, 2002
Validation of Spanish Language Dyspepsia Questionire
, 2002
Quantifying the population impact of a prophylactic Helicobacter pylori vaccine
, 2001
Determition of the infectious dose of Helicobacter pylori during primary
, 2001
Acute Helicobacter pylori infection is followed by an increase
, 2001
Helicobacter pylori and risk for gastric adenocarcinoma.
, 2001
Screening markers for chronic atrophic gastritis in Chiapas, Mexico
, 2001
Gastric atrophy and extent of intestil metaplasia in a cohort of Helicobacter pylori
, 2001
Is anything safe to eat?
, 2001
Histological classification of gastric adenocarcinoma for epidemiological research
, 2001
Helicobacter pylori infection and gastric cancer
, 2001
Variability of serologic testing for H-pylori using US and Peruvian antigens
, 2001
Confirmatory serologic testing for acute toxoplasmosis
, 2001
A dymic transmission model for predicting trends in Helicobacter pylori
, 2000
When heredity is infectious
, 2000
Interobserver variability in application of the revised Sydney classification for gastritis
, 1999
Helicobacter pylori vaccine development and use
, 1999
Prevalence and incidence of herpes simplex virus type 2 infection among male Zimbabwean factory
, 1999
Helicobacter pylori and gastric cancer
, 1999
Helicobacter pylori virulence and genetic geography
, 1999
Rhesus monkey (Macaca mulatta) model of Helicobacter pylori
, 1999
Patterns of health seeking behavior during episodes of childhood diarrhea
, 1999
Microbes and Maligncy: Infection as a Cause of Human Cancer
Gastrin and colorectal cancer: A prospective study
, 1998
Helicobacter pylori: the size of the problem
, 1998
Helicobacter pylori
, 1998
Helicobacter pylori infection and uriry excretion of 8-hydroxy-2-deoxyguanosine
, 1998
Advances in the prevention and magement of traveler's diarrhea.
, 1998
Risk for gastric lymphoma in persons with CagA(+) and CagA(-) Helicobacter pylori infection
, 1997
Molecular mechanisms for inflammation-promoted pathogenesis of cancer
, 1997
Uriry phytoestrogen levels in young women from a multiethnic population
, 1997
Seroprevalence of CagA-positive strains among Helicobacter pylori-infected, healthy young adults
, 1997
Should we treat H. pylori infection to prevent gastric cancer?
, 1997
Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection
, 1997
Association between prior cytomegalovirus infection
, 1997
Helicobacter pylori in the stomach - A paradox unmasked
, 1996
Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer
, 1996
Epidemiology of gastric non-Hodgkin's lymphoma patients: parallels with Helicobacter pylori.
, 1996
Principles of screening and surveillance
, 1996
Increased risk of Helicobacter pylori associated with birth in wartime and post-war Japan
, 1996
Bacterial infection as a cause of cancer
, 1995
BIOLOGIC SEX AS A RISK FACTOR FOR HELICOBACTER-PYLORI INFECTION IN HEALTHY-YOUNG ADULTS
, 1995
FLAGELLAR SEROTYPES OF SALMONELLA-TYPHI IN INDONESIA - RELATIONSHIPS AMONG MOTILITY, INVASIVENESS
, 1995
THE INCIDENCE OF HELICOBACTER-PYLORI INFECTION
, 1995
GASTRIC ADENOCARCINOMA AND HELICOBACTER-PYLORI INFECTION
, 1994
PARASITISM BY THE SLOW BACTERIUM HELICOBACTER
, 1994
THE EPIDEMIOLOGY OF TUBERCULOSIS IN SAN-FRANCISCO
, 1994
H pylori and gastric cancer.
, 1994
AZATHIOPRINE HYPERSENSITIVITY MIMICKING SEPSIS IN A PATIENT WITH CROHNS-DISEASE
, 1993
HELICOBACTER-PYLORI, PEPSINOGEN, AND RISK FOR GASTRIC ADENOCARCINOMA
, 1993
CHRONIC IDIOPATHIC DIARRHEA
, 1993
ANOTHER CASE OF POLYMYOSITIS AFTER CIGUATERA TOXIN EXPOSURE
, 1993
HELICOBACTER-PYLORI AND GASTRIC-CANCER
, 1993
PARAQUAT POISONING IN SOUTHERN MEXICO - A REPORT OF 25 CASES
, 1993
THE ASSOCIATION OF HELICOBACTER-PYLORI WITH GASTRIC
, 1993
Hemolytic uremic syndrome: clinical picture and bacterial connection.
, 1993
SALT INTAKE AND STOMACH-CANCER - SOME CONTRARY EVIDENCE
, 1992
SYMPTOMS AND RISK-FACTORS OF HELICOBACTER-PYLORI INFECTION IN A COHORT OF EPIDEMIOLOGISTS
, 1992
POLYMYOSITIS AFTER CIGUATERA TOXIN EXPOSURE
, 1991
HELICOBACTER-PYLORI INFECTION IN INTESTIL-TYPE AND DIFFUSE-TYPE GASTRIC ADENOCARCINOMAS
, 1991
MOLECULAR EPIDEMIOLOGIC TECHNIQUES IN ALYSIS OF EPIDEMIC AND ENDEMIC SHIGELLA-DYSENTERIAE TYPE
, 1991
MULTIFOCAL COLITIS ASSOCIATED WITH AN EPIDEMIC OF CHRONIC DIARRHEA
, 1991
ASSOCIATION OF HELICOBACTER
, 1990
Surveillance imaging during remission identifies a group of patients
, 1989
SHIGELLA-DYSENTERIAE TYPE-1 INFECTIONS IN UNITED-STATES TRAVELERS TO MEXICO, 1988
, 1989
TRICHOSPORON-BEIGELII PERITONITIS
, 1989
INTERTIOL TRAVEL AND THE CHILD YOUNGER THAN 2 YEARS .1. RECOMMENDATIONS FOR IMMUNIZATION
, 1989
CHRONIC DIARRHEA ASSOCIATED WITH DRINKING UNTREATED WATER
, 1989
SIMPLE MICROBIOLOGIC DETECTION OF CAMPYLOBACTER-PYLORI
, 1988
What is Dr. Parsonnet's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Parsonnet's National Provider Identifier (NPI) number is 1083771646.
What common questions do patients ask about Dr. Parsonnet?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Parsonnet
What is Dr. Julie Parsonnet's specialty?
Dr. Parsonnet is a Infectious Disease Specialist near Stanford, CA.
What does an Infectious Disease Specialist do?
An internist who deals with infectious diseases of all types and in all organ systems. Conditions requiring selective use of antibiotics call for this special skill. This physician often diagnoses and treats AIDS patients and patients with fevers which have not been explained. Infectious disease specialists may also have expertise in preventive medicine and travel medicine.
Is this Dr. Julie Parsonnet affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Parsonnet is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
When to see an Infectious Disease Specialist?: Guides for symptoms, conditions, and treatments
Understand your symptoms and know when it’s time to see an Infectious Disease Specialist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Julie Parsonnet accepting new patients in Stanford, CA?
Yes, Dr. Julie Parsonnet is accepting new patients at this time.
Does Dr. Julie Parsonnet offer online booking?
Please contact Dr. Parsonnet's office at (650) 723-4000 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Julie Parsonnet?
Please contact Dr. Parsonnet's office at (650) 723-4000 for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. Julie Parsonnet have?
Dr. Julie Parsonnet is certified by the American Board of Internal Medicine.
Other Infectious Disease Specialist Near Stanford, CA
Infectious Disease Specialist
Accepting patientsInfectious Disease Specialist
Accepting patients
Infectious Disease Specialist
Accepting patients